ARC’s Inaugural Masterclass a Success!
In early January, ARC hosted its first Masterclass, 'Mastering the Art and Science of Amyloidosis.' Over 75 healthcare providers were in attendance for the broad range of topics and comprehensive training, taught by leading amyloidosis experts. (more…)
Read More
ARC's 2019 Achievements
ARC is Poised for Great Things in 2020
2019 was a year of great accomplishments for the Amyloidosis Research Consortium (ARC), and we are grateful to all of you who have so generously supported our efforts to accelerate the pace of development of drugs to treat and improve...
Read More
FDA Amyloidosis Forum
Report from the Amyloidosis Forum’s Initial Meeting at FDA
The inaugural Amyloidosis Forum took place on November 12th, 2019 at FDA’s White Oak Campus in Silver Spring, MD. We could not have hoped for a better turnout, a more spirited and productive discussion. (more…)
Read More
ARC Developing a Disease-Specific PRO Tool for Patients with ATTR Amyloidosis
ARC is developing a patient-reported outcome (PRO) measurement tool in ATTR amyloidosis to be used to understand and measure the impact of the disease on patients from the patient’s perspective. (more…)
Read More
ARC Amyloidosis Masterclass: The Art and Science of Managing Amyloidosis
Amyloidosis Masterclass: The Art and Science of Managing Amyloidosis
The Amyloidosis Research Consortium (ARC) is excited to announce the first in a series of physician education “Masterclasses” to take place on January 10, 2020 in Dallas, TX. (more…)
Read More

320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170

ARC is a 501(c)(3) nonprofit organization